[1] Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis[J]. Lancet, 2021,398 (10308): 1359-1376.
[2] GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol,2020,5 (3): 245-266.
[3] 陈成伟, 费瑞高, 李锡寿, 等. 人胎肝细胞治疗慢性活动性肝炎的疗效初步观察[J]. 中华传染病杂志,1988(3):5.
[4] Cardinale V, Carpino G, Gentile R, et al. Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis[J]. BMC Gastroenterol,2014,14: 204.
[5] Pietrosi G, Vizzini G, Gerlach J, et al. Phases I-II Matched Case-Control Study of Human Fetal Liver Cell Transplantation for Treatment of Chronic Liver Disease[J]. Cell Transplant,2015,24 (8) 1627-1638.
[6] Khan AA, Shaik MV, Parveen N,et al. Habibullah, Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis[J]. Cell Transplant,2010,19:409-418.
[7] Tsuchiya A, Takeuchi S, Watanabe T, et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration[J]. Inflamm Regen,2019,39:18.
[8] Suk KT, Yoon JH, Kim MY, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial[J]. Hepatology,2016,64 (6) 2185-2197.
[9] Salama H, Zekri AR, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease[J]. Stem Cell Res Ther,2014, 5 (3): 70.
[10] Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes[J]. Hepatology,2011,54 (3) 820-828.
[11] Miyajima A, Tanaka M, Itoh T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming[J]. Cell Stem Cell,2014,14 (5) 561-574.
[12] Roskams TA, Theise ND, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers[J]. Hepatology,2004,39 (6) 1739-1745.
[13] Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors[J]. J Exp Med,2007,204 (8): 1973-1987.
[14] Dan YY, Riehle KJ, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages[J]. Proc Natl Acad Sci U S A.,2006,103 (26) 9912-9917.
[15] Michalopoulos GK, Barua L, Bowen WC. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury[J]. Hepatology,2005,41 (3): 535-544.
[16] Tarlow BD, Pelz C, Naugler WE, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes[J]. Cell Stem Cell,2014,15(5):605-618.
[17] Li W, Yang L, He Q,et al. A Homeostatic Arid1a-Dependent Permissive Chromatin State Licenses Hepatocyte Responsiveness to Liver-Injury-Associated YAP Signaling[J]. Cell Stem Cell, 2019,25 (1):54-68.
[18] Li L, Cui L, Lin P, et al. Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers[J]. Cell Stem Cell, 2023,30 (3):283-299.e9.
[19] Dai Z, Song G, Balakrishnan A,et al. Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells[J]. Gut,2020,69 (6):1104-1115.
[20] Lin Y, Fang ZP, Liu HJ, et al. HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells[J]. Nat Commun,2017, 8 (1): 1175.
[21] Lu WY, Bird TG, Boulter L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity[J]. Nat Cell Biol,2015,17 (8): 971-983.
[22] Wu H, Zhou X, Fu GB,et al. Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion[J]. Cell Res ,2017,27 (5) 709-712.
[23] Fu GB, Huang WJ, Zeng M, et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens[J]. Cell Res,2019,29 (1):18-22.
[24] Huang WJ, Zhou X, Fu GB, et al. The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction[J]. Theranostics,2021,11 (11) :5539-5552.
[25] Nevens F, Gustot T, Laterre PF, et al. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation[J]. JHEP Rep, 2021,3 (4): 100291.
[26] 吕少诚, 王苑, 潘冰, 等. 肝移植术后肺部感染的诊治及其危险因素[J]. 中华肝胆外科杂志,2018,24 (6):371-375. |
